Peers of XBiotech Inc (XBIT)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
-268.67x
As of Dec 29, 2023
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Dec 29, 2023 | -268.67x |
| Dec 28, 2023 | -271.71x |
| Dec 27, 2023 | -268.67x |
| Dec 26, 2023 | -275.76x |
| Dec 22, 2023 | -276.77x |
| Dec 21, 2023 | -269.68x |
| Dec 20, 2023 | -274.75x |
| Dec 19, 2023 | -257.52x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison